This inventor holds 1 USPTO granted patent. Top assignee: Teikoku Hormone Mfg. Co., Ltd.. Active years: 1981.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1981
Title: The Innovations of Hideki Sakuma
Introduction
Hideki Sakuma is a notable inventor based in Yokohama, Japan. He has made significant contributions to the field of medicinal chemistry, particularly in the development of antiulcer agents. His work has led to the creation of innovative compounds that have potential therapeutic applications.
Latest Patents
Sakuma holds a patent for antiulcer phenoxypropylamine derivatives. The patent describes phenoxypropylamine derivatives of the general formula wherein R1 represents a hydrogen atom or a methyl or ethyl group. R2 and R3 can independently represent a lower alkyl group or together form a linear alkylene group having 4 to 7 carbon atoms, which may be optionally substituted by a hydroxyl or hydroxymethyl group. R4 represents a hydrogen atom or a group of the formula --R5--Z, where R5 is a lower alkylene group, and Z can be a variety of functional groups. This patent outlines a process for the production of these compounds and their medicinal use, particularly as antiulcer agents.
Career Highlights
Sakuma is associated with Teikoku Hormone Mfg. Co., Ltd., where he has been able to apply his expertise in medicinal chemistry. His work has contributed to advancements in pharmaceutical formulations and therapeutic agents.
Collaborations
Throughout his career, Sakuma has collaborated with notable colleagues, including Kenyu Shibata and Toshihisa Itaya. These collaborations have fostered innovation and development in their respective fields.
Conclusion
Hideki Sakuma's contributions to the field of medicinal chemistry, particularly through his patent for antiulcer agents, highlight his role as an influential inventor. His work continues to impact the pharmaceutical industry positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile